YTYi Tang

Yi Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yi Tang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Rong Su

    Department of Breast Surgery, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    2 shared publications
  • Yong Liu

    Department of Paeditrics The Seventh Affiliated Hospital, Sun Yat‐Sen University Guangzhou China

    2 shared publications
  • Donglan Tang

    Department of Breast Surgery, The Third Affiliated Hospital of Guangzhou Medical University Guangzhou 510150, P. R. China

    1 shared publication
  • Jiaming Wang

    Department of Breast Surgery, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    1 shared publication
  • Shiyang Zheng

    Department of Breast Surgery, The Third Affiliated Hospital of Guangzhou Medical University Guangzhou 510150, P. R. China

    1 shared publication
  • Xiaoli Liao

    Department of Radiotherapy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    Postoperative radiotherapy-induced leiomyosarcoma in breast cancer: a case report and literature review

    by Yong Liu, Jiaming Wang, Rong Su, Yi Tang, Xiaoli Liao

    Radiation-induced sarcoma (RIS) is a late complication of breast cancer radiotherapy, with a very low incidence, long latent period and poor prognosis. Among them, leiomyosarcoma after radiation is an extremely rare radiation-associated sarcoma. In this study, we report a case of radiation-induced leiomyosarcoma 2 years after postoperative radiotherapy for breast cancer. After the diagnosis of leiomyosarcoma, the patient received radical resection of the left chest wall leiomyosarcoma. The patient showed no relapse or progression during the follow-up time of 1 year after operation. Rare occurrence of RIS induced by postoperative radiotherapy in breast cancer and limited experience concerning its diagnosis and treatment bring obstacle to both patients and doctors. Preoperative examinations must be carefully refined. With a perfect coordination between different disciplines, RIS induced by postoperative radiotherapy in breast cancer can be ideally treated with better prognosis.


    • 1 January 2019
      • Vol. 12  (11) , 3982-3991

    Serum microRNA-195 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis

    by Yong Liu, Donglan Tang, Shiyang Zheng, Rong Su, Yi Tang

    Serum microRNA-195 (miR-195) expression has been shown to be significantly up-regulated in breast cancer, which implies that it could be a useful biomarker in the early detection of breast cancer. Hence, we performed this meta-analysis to investigate the diagnostic value of miR-195 for breast cancer. Relevant articles were collected from PubMed, Scopus, Embase, the Cochrane Library, BioMed Central, ISI Web of Knowledge, China National Knowledge Infrastructure, Wan Fang Data and Technology of Chongqing databases, from inception to May 24, 2019, by two independent researchers. The diagnostic capacity of miR-195 for breast cancer was assessed using pooled sensitivity and specificity, diagnostic odds ratio (DOR), area under the summary receiver operating characteristic (AUC) and Fagan's nomogram. Meta-analysis and heterogeneity source investigation were completed using Meta-Disc statistical software and Stata SE (version 14.0). Six studies with a total of 464 patients and 287 healthy controls were included in our meta-analysis. The pooled results for sensitivity, specificity and DOR were 0.79 (95% CI: 0.75-0.83), 0.86 (95% CI: 0.82-0.90) and 32.05 (95% CI: 17.04-60.30), respectively; positive and negative likelihood ratios were 5.18 and 0.20, and AUC was 0.9197 (95% CI: 0.86-0.91). In addition, heterogeneity was clearly apparent but was not caused by the threshold effect. In summary, this meta-analysis revealed that miR-195 may be suitable as a potential biomarker for early diagnosis of breast cancer with high sensitivity and specificity, and further investigations are needed to demonstrate its clinical application value.